| 2024 | | Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2024 | | Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2024 | | Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 서창희 |
| 2024 | | Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview | 서창희 |
| 2023 | | Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study | 서창희 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2023 | | Association between CCR2 and CCL2 expression and NET stimulation in adult-onset Still’s disease | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2023 | | Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | The transcription factor Mef2d regulates B:T synapse–dependent GC-TFH differentiation and IL-21–mediated humoral immunity | 김지원, 서창희 |
| 2023 | | Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
| 2022 | | Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis | 서창희 |
| 2022 | | Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren’s syndrome | 강정현, 김지원, 김현아, 노진, 서창희, 안영실, 정주양, 한재호 |
| 2022 | | Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool | 김지원, 김현아, 박성훈, 서창희, 정주양 |
